Empagliflozin Reversal of Arterial StiffnEss in Aging — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Empagliflozin Reversal of Arterial StiffnEss in Aging — Stella

View on ClinicalTrials.gov

Recruiting

Back to Aging trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Missouri, Columbia, Missouri

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

University of Missouri-Columbia

Enrollment target

~80 participants

Started

August 2024

Primary completion

October 2028

Age range

60 Years – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.